2020
DOI: 10.4103/idoj.idoj_234_20
|View full text |Cite
|
Sign up to set email alerts
|

Management of leprosy in the context of COVID-19 pandemic: Recommendations by SIG leprosy (IADVL academy)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 19 publications
(6 citation statements)
references
References 11 publications
0
5
0
1
Order By: Relevance
“…[12] Possible reasons for defaulting treatment may include limited access to healthcare services, socioeconomic challenges, non-compliance due to treatment reactions and side-effects, stigma and the impact of COVID-19 restrictions. [11,[38][39][40] Recent studies involving patients with pulmonary tuberculosis in our setting showed higher rates of completion of treatment in patients who participated in directly observed therapy short course (DOTS). [41,42] Similar results were noted in patients with leprosy globally.…”
Section: Complicationsmentioning
confidence: 99%
“…[12] Possible reasons for defaulting treatment may include limited access to healthcare services, socioeconomic challenges, non-compliance due to treatment reactions and side-effects, stigma and the impact of COVID-19 restrictions. [11,[38][39][40] Recent studies involving patients with pulmonary tuberculosis in our setting showed higher rates of completion of treatment in patients who participated in directly observed therapy short course (DOTS). [41,42] Similar results were noted in patients with leprosy globally.…”
Section: Complicationsmentioning
confidence: 99%
“…Nonetheless, patients should be informed of the side effects and possible complications associated with leprosy reactions and neuritis. Prednisolone causes immunosuppression in a dosage >10 mg/d or a total cumulative dosage >700 mg [41]. The use of systemic steroids places patients at higher risk of severe COVID-19 infection and complications.…”
Section: Impact Of the Covid-19 Pandemicmentioning
confidence: 99%
“…The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Special Interest Group (SIG) on leprosy, under the aegis of the IADVL Academy, published recommendations for the management of leprosy in the context of the coronavirus disease (COVID-19) pandemic based on available evidence and expert opinion in 2020. [ 1 ] These were deliberated and brought out early in the pandemic to benefit dermatologists and leprologists, regarding the management of leprosy cases with the advent of this novel virus. A couple of factors, that is, the plethora of data published regarding COVID-19 in the past year and the unprecedented surge which India witnessed, the SIG-leprosy sought to revisit these recommendations.…”
Section: Introductionmentioning
confidence: 99%
“…Salient changes in the recommendations between version 1[ 1 ] and the current version with level of evidence are summarized in Table 1 .…”
Section: Introductionmentioning
confidence: 99%